Prot# E7080-G000-303: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of E7080 in (131) I-Refractory Differentiated Thyroid Cancer

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/27/122/27/21

Funding

  • PPD Development (E7080-G000-303)
  • Eisai, Inc. (E7080-G000-303)